MedTrace Logo

Iodine Supplementation in Obesity

NCT01985204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2014-07-30

No results posted yet for this study

Summary

The study hypothesis is that iodine supplementation will lower serum TSH and leptin concentrations and thereby improve the lipid and glucose profile.

Conditions

  • Iodine Deficiency
  • Subclinical Hypothyroidism

Interventions

DIETARY_SUPPLEMENT

Iodine tablet

Iodine tablets containing 200 ug iodine as potassium iodate

DIETARY_SUPPLEMENT

Placebo tablet

Placebo tablet without iodine

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Isabelle Aeberli, PhD · ETH Zurich (Switzerland)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • Morocco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01985204 on ClinicalTrials.gov